Peptide receptor radionuclide therapy as neoadjuvant treatment in pancreatic neuroendocrine tumours

被引：0
|
作者：
Prospero, I. [1 ]
Ferreira, G. [1 ]
Ferro, J. C. [1 ]
Barbosa, D. [1 ]
Silva, D. G. [1 ]
Fontao de Castro, S. [1 ]
Teixeira, J. P. [1 ]
Duarte, H. [1 ]
Lucena Sampaio, I. [1 ]
机构：
[1] Inst Portugues Oncol Porto, Porto, Portugal
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2023年 / 50卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-473
引用
收藏
页码：S220 / S220
页数：1
相关论文
共 50 条
  • [31] Histopathological and Immunophenotypic Changes of Pancreatic Neuroendocrine Tumors after Neoadjuvant Peptide Receptor Radionuclide Therapy (PRRT)
    Schiavo Lena, Marco
    Partelli, Stefano
    Castelli, Paola
    Andreasi, Valentina
    Smart, Chanel Elisha
    Pisa, Eleonora
    Bartolomei, Mirco
    Bertani, Emilio
    Zamboni, Giuseppe
    Falconi, Massimo
    Doglioni, Claudio
    ENDOCRINE PATHOLOGY, 2020, 31 (02) : 119 - 131
  • [32] Value of Peptide Receptor Radionuclide Therapy as Neoadjuvant Treatment in the Management of Primary Inoperable Neuroendocrine Tumors
    Opalinska, Marta
    Sowa-Staszczak, Anna
    Grochowska, Anna
    Olearska, Helena
    Hubalewska-Dydejczyk, Alicja
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [33] Peptide receptor radionuclide therapy in entero-pancreatic neuroendocrine tumours: a multidisciplinary approach at the European Institute of Oncology
    Bodei, L.
    Baio, S. M.
    Fazio, N.
    Grana, C. M.
    Bonomo, G.
    Luca, F.
    Lorizzo, K.
    Ravizza, D.
    Gibelli, B.
    Monfardini, L.
    De Cicco, C.
    Pelosi, G.
    Arico, D.
    de Braud, F.
    Paganelli, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S350 - S350
  • [34] Efficacy of Peptide Receptor Radionuclide Therapy in Patients with Advanced Bronchial Neuroendocrine Tumours
    Koffas, A.
    Popat, R.
    Mohmaduvesh, M.
    Quigley, A. M.
    Navalkissoor, S.
    Caplin, M.
    Toumpanakis, C.
    NEUROENDOCRINOLOGY, 2016, 103 : 81 - 81
  • [35] Peptide receptor radionuclide therapy in non-neuroendocrine tumours - a field report
    Nilica, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S223 - S223
  • [36] Peptide receptor radionuclide therapy for patients with advanced pancreatic neuroendocrine tumors
    Ramage, John
    Naraev, Boris G.
    Halfdanarson, Thorvardur R.
    SEMINARS IN ONCOLOGY, 2018, 45 (04) : 236 - 248
  • [37] Neoadjuvant Downsizing by Internal Radiation A Case for Preoperative Peptide Receptor Radionuclide Therapy in Patients With Pancreatic Neuroendocrine Tumors
    Ezziddin, Samer
    Lauschke, Holger
    Schaefers, Michael
    Meyer, Carsten
    van Essen, Martijn
    Biersack, Hans-Juergen
    Kwekkeboom, Dik J.
    Ahmadzadehfar, Hojjat
    CLINICAL NUCLEAR MEDICINE, 2012, 37 (01) : 102 - 104
  • [38] Peptide receptor radionuclide therapy versus capecitabine/ temozolomide for the treatment of metastatic pancreatic neuroendocrine tumors
    Gujarathi, R.
    Tobias, J.
    Azar, S. A.
    Keutgen, X.
    Liao, C-Y.
    ANNALS OF ONCOLOGY, 2024, 35 : S94 - S94
  • [39] Peptide Receptor Radionuclide Therapy versus Capecitabine/Temozolomide for the Treatment of Metastatic Pancreatic Neuroendocrine Tumors
    Gujarathi, Rushabh
    Tobias, Joseph
    Abou Azar, Sara
    Keutgen, Xavier M.
    Liao, Chih-Yi
    CANCERS, 2024, 16 (17)
  • [40] Peptide Receptor Radionuclide Therapy as First Line Systemic Treatment in Advanced Inoperable/Metastatic Neuroendocrine Tumours
    Satapathy, Swayamjeet
    Sood, Ashwani
    Sood, Apurva
    Mittal, Bhagwant
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
12345